AYALA PHARMACEUTICALS INC (AYLA) Earnings History & Surprises

NASDAQ:AYLA • US05465V1089

Current stock price

0.5036 USD
+0.03 (+5.84%)
Last:

AYLA Earnings overview

Past quarterly earnings results for AYALA PHARMACEUTICALS INC (AYLA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 27, 2023
Period
Q4 / 2022
EPS Estimate
-$0.74
Revenue Estimate
408K

Last Reported

Most Recent
Release Date
Nov 3, 2022
Period
Q3 / 2022
EPS Reported
-$0.66
EPS Surprise
-30.98%
Revenue Surprise
-85.61%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 -0.66 -0.50 -30.98% 2.94% 91K 632.4K -85.61% -85.44%
Q2 2022 -0.54 -0.67 18.82% 28.00% 38K 629.003K -93.96% -95.01%
Q1 2022 -0.66 -0.69 4.31% 10.81% 458K 846.6K -45.90% -52.78%
Q4 2021 -0.66 -0.62 -6.83% 9.59% 1.146M 707.441K 61.99% 14.60%
Q3 2021 -0.68 -0.81 16.25% -15.25% 625K 856.8K -27.05% -5.30%
Q2 2021 -0.75 -0.64 -17.51% -1.35% 761K 1.044M -27.11% -27.52%
Q1 2021 -0.74 -0.72 -2.66% 43.94% 970K 1.326M -26.85% -3.00%
Q4 2020 -0.73 -0.59 -22.97% - 1M 547.403K 82.68% -
Q3 2020 -0.59 -0.56 -6.20% - 660K - -
Q2 2020 -0.74 -0.54 -37.27% - 1.05M 425.003K 147.06% -
Q1 2020 -1.32 -0.77 -71.18% - 1M 282.203K 254.35% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AYLA EPS Q2Q GrowthAYLA EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 10 -10 20 30 40

Revenue Historical Q2Q growth and Acceleration

AYLA Revenue Q2Q GrowthAYLA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-3.67%
Max EPS beat (4)
18.82%
Min EPS beat (4)
-30.98%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-40.87%
Max Revenue beat (4)
61.99%
Min Revenue beat (4)
-93.96%

Analysis

In the last 4 quarters, AYLA has beaten EPS estimates in 2 out of 4 releases
AYLA has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, AYLA reported -3.7% below the EPS estimates on average.
In the last 4 quarters, AYLA reported -40.9% below the revenue estimates on average.
AYLA Overview AYLA Technical Analysis Report AYLA Fundamental Analysis Report AYLA Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

AYALA PHARMACEUTICALS INC / AYLA Earnings FAQ

Can you provide the last earnings date for AYALA PHARMACEUTICALS INC?

AYALA PHARMACEUTICALS INC (AYLA) last reported earnings on 11/3/2022.

Did AYALA PHARMACEUTICALS INC (AYLA) beat earnings estimates last quarter?

AYALA PHARMACEUTICALS INC (AYLA) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often AYALA PHARMACEUTICALS INC beats earnings estimates?

In the last 4 quarters, AYALA PHARMACEUTICALS INC (AYLA) has beaten EPS estimates in 2 out of 4 releases.